Guardant Health Presents Data Demonstrating Utility of Comprehensive Genetic Profiling with Guardant360® Liquid Biopsy Test to Guide Treatment for Advanced Breast Cancer Patients at 2021 San Antonio Breast Cancer Symposium

GuardantINFORM™Â platform offers real-world evidence to identify unmet need for patients with advanced breast cancer December 06, 2021 08:05 AM Eastern Standard Time REDWOOD CITY, Calif.–(BUSINESS WIRE)–sGuardant Health, Inc. (Nasdaq: GH),...

Under the MoU, the Asia Pacific Center of Excellence in Translational Science (AP CoE-TS) under Janssen AP R&D will work with OrigiMed in harnessing real-world data (RWD) for regulatory use and apply innovative applications to accelerate clinical development.

Pharmaceutical giant Johnson & Johnson has strengthened cooperation with Shanghai to further drive local innovative health-care solutions. Janssen (China) Research and Development Center of Johnson & Johnson (China) Investment Co...